Is $AARD pump-proof?

Aardvark Therapeutics, Inc. — trap-risk read from social crowding, price extension, and SEC disclosure flags. Updated 2026-07-11.

$AARD
Aardvark Therapeutics, Inc.
CAUTION RISK
51
/ 100 trap score
Quiet price action, but note the dilution setup on file — worth knowing before any rally.
Hype / crowding
50
Run-up / extension
42
Structural risk
60
$Prospectus supplement (424B5) filed 3 months ago — consistent with an at-the-market program: the company can sell new shares into this strength
4 more flags — filing links, dates, and the full breakdown.Pro — coming soon · get notified ↓
PumpProof · pumpproof.com
as of 2026-07-11 · not financial advice
Check any other ticker free at pumpproof.com

Get the weekly trap report

The most dangerous hyped stocks of the week — scores, red flags, and what the chatter isn't telling you. Free, in your inbox.

Is $AARD a trap? Aardvark Therapeutics, Inc. — PumpProof score 51/100